Conditions in which there is histological damage to the lower epidermis along with a grouped chronic inflammatory infiltrate in the papillary dermis disturbing the interface between the epidermis and dermis. LICHEN PLANUS is the prototype of all lichenoid eruptions. (From Rook et al., Textbook of Dermatology, 4th ed, p398)
The emergence of a tooth from within its follicle in the ALVEOLAR PROCESS of the MAXILLA or MANDIBLE into the ORAL CAVITY. (Boucher's Clinical Dental Terminology, 4th ed)
The ash, dust, gases, and lava released by volcanic explosion. The gases are volatile matter composed principally of about 90% water vapor, and carbon dioxide, sulfur dioxide, hydrogen, carbon monoxide, and nitrogen. The ash or dust is pyroclastic ejecta and lava is molten extrusive material consisting mainly of magnesium silicate. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.

Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. (1/39)

BACKGROUND AND OBJECTIVES: Standard or investigative immunosuppressive therapies for cutaneous chronic graft-versus-host disease (GVHD) may prove not only ineffective but also cause serious adverse effects. Repeated exposure of the skin to ultraviolet radiation in the wavelength range 340-400 nm (so-called ultraviolet A1) was recently reported to have a strong local (intracutaneous) immunomodulatory activity. This study was undertaken to evaluate efficacy and safety of this phototherapy. DESIGN AND METHODS: Nine patients with cutaneous (4 lichenoid and 5 sclerodermoid) GVHD and mild or no other organ involvement were enrolled. All patients had developed serious drug toxicity and/or opportunistic infections. Phototherapy was administered three times a week. RESULTS: Complete remission was seen in 5 (2 lichenoid and 3 sclerodermoid) cases and a partial improvement in 4 (2 lichenoid and 2 sclerodermoid) after having received 15.8+/-3.8 (lichenoid GVHD) or 21.6+/-8.0 (sclerodermoid GVHD) sessions of phototherapy. Adverse effects were not registered. At follow-up (range: 6-25 months), two patients with sclerodermoid lesions relapsed after 5 months but responded to another treatment cycle. Patients with lichenoid GVHD showed relapses within one month and prolonged maintenance phototherapy was needed. Problems of drug toxicity and opportunistic infections improved as phototherapy allowed the reduction or interruption of systemic drug therapies. INTERPRETATION AND CONCLUSIONS: Ultraviolet A1 phototherapy may be considered as an appropriate therapeutic approach for sclerodermoid GVHD with no or mild involvement of internal organs. Patients with lichenoid GVHD should be treated only if they develop serious adverse effects to immunosuppressive therapies and opportunistic infections because of the carcinogenic hazard of high cumulative doses of ultraviolet A1 radiation.  (+info)

The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus. (2/39)

BACKGROUND: Regression is a phenomenon present in a variety of cutaneous lesions. It is likely that similar immunologic mechanisms explain the phenomenon of spontaneous regression occurring in the various lesions. METHODS: Twenty-seven specimens, nine each of halo nevus, keratoacanthoma, and benign lichenoid keratosis, including three examples each of predominantly early, mid, and late regression were examined with antibodies to HLA-II, CD1a, CD3, CD4, CD8, CD20, CD34, CD56, and CD68. RESULTS: Epidermotropism of inflammatory cells, including CD1a positive, CD68 positive, CD3 positive, and CD8 positive cells, was present in benign lichenoid keratosis and keratoacanthoma, but not in halo nevus. In halo nevus, the nests of halo nevus cells tended to be infiltrated by CD1a positive, CD68 positive, CD3 positive, and CD8 positive cells. The blood vessels exhibited endothelial cell swelling with luminal narrowing and disruption within the dermis of all lesions. The CD1a positive cells were increased in number in lesional epidermis except in keratoacanthoma lesions where the density of CD1a positive cells was increased in the epithelial lip, but decreased within the epithelial portion of the keratoacanthoma proper. Conversely, the CD8 positive cells were scarce in the dermis below the epithelial lip of the keratoacanthoma, but increased in the dermis of the neoplastic epithelium. CD1a positive cells were also seen throughout the dermal portion of the lesion, particularly at the lesion base. In halo nevus, the CD1a positive cells and CD68 positive cells within the lesions were larger than those in non-lesional skin, indicating activation. The composition of the inflammatory infiltrate varied within each lesion type according to stage of regression, but T-lymphocytes predominated. CONCLUSION: Cytotoxic T-cells may be the final common denominator of regression in benign lichenoid keratosis, keratoacanthoma, and halo nevus. In halo nevus, cytotoxic T-cells may play the predominant role in regression. In keratoacanthoma and benign lichenoid keratosis, cytotoxic T-cells play a pivotal role, but additional mechanisms may also be involved in the phenomenon of regression. Benign lichenoid keratoses progress through stages of regression accompanied by varying proportions of inflammatory cells, including CD3, CD4, and CD8 positive T-lymphocytes, natural killer cells, macrophages and Langerhans cells.  (+info)

Progressive familial intrahepatic cholestasis with normal GGT level appearing with lichenification and enlargement of hands and feet. (3/39)

Progressive familial intrahepatic cholestasis is a serious disease of the liver, known as Byler disease, characterized by hepatocellular cholestasis. Severe pruritus and high serum bile acid concentrations are the most important diagnostic criteria of this autosomal recessive inherited disease. Here, we present a five-year-old boy with lichenification and enlargement of hands and feet as a sign of progressive familial intrahepatic cholestasis due to severe pruritus.  (+info)

Lichen amyloidosus: a study of clinical, histopathologic and immunofluorescence findings in 30 cases. (4/39)

BACKGROUND: Lichen amyloidosus (LA) is a primary localized cutaneous amyloidosis characterized clinically by discrete hyperkeratotic hyperpigmented papules and histologically by deposition of amyloid material in previously normal skin without any evidence of visceral involvement. AIMS AND OBJECTIVES: The aim of this work was to study the etiology, clinical features, histopathology and direct immunofluorescence findings in LA. METHODS: A prospective study of 30 patients with clinical, histological and immunofluorescence findings suggestive of LA was undertaken. After a detailed history and clinical examination, two punch biopsies for histopathology and immunofluorescence were taken. RESULTS: Of the 30 patients, 19 (63.3%) were males and 11 (36.7%) were females with duration of LA ranging from 6-20 months. Pruritus was the presenting symptom in 27 (90%) patients. Shin was involved in 26 (86.7%) followed by arms in three (10%) and back in one (3.3%). Seventeen patients (56%) had used scrubs for more than 2 years. Histopathology, direct immunofluorescence and Congo red staining detected amyloid in all cases. CONCLUSIONS: LA commonly presents over the shins as pruritic discrete hyperpigmented papules. Familial predisposition and friction may have a pathogenic role. Histopathological examination is very useful in the detection of amyloid which may be supplemented with direct immunofluorescence and Congo red staining.  (+info)

Cutaneous tuberculosis and phlyctenular keratoconjunctivitis: a forgotten association. (5/39)

Cutaneous tuberculosis may be associated with concurrent systemic foci in the body such as lung, lymph node, bone or CNS. Phlyctenular keratoconjunctivitis (PKC) is a manifestation of immunological response to a variety of antigens in the eye, tubercular focus (evident or occult) being the commonest in India. Reports in the existing literature have shown lungs and lymph nodes to be the predominant underlying focus associated with PKC, whereas cutaneous tuberculosis has seldom been found in this situation. We report this forgotten association in two children with cutaneous tuberculosis, one each with lupus vulgaris and scrofuloderma, who also had PKC. Interestingly, one of the cases also had simultaneous lichen scrofulosorum, which is also an immunological response to tubercular antigen and manifests in the skin, thus showing immunological manifestation in two different organ systems along with cutaneous focus of tuberculosis.  (+info)

Histochemical analysis of pathological alterations in oral lichen planus and oral lichenoid lesions. (6/39)

Lichen planus is a dermatologic disease of unknown etiology characterized by keratotic plaques on the skin. Many patients also harbor white lesions of the oral mucosa. The literature contains numerous reports of lichen planus-like lesions evolving in conjunction with the administration of a variety of pharmacologic agents. It is difficult, if not impossible, to distinguish such lesions from one another. The present study evaluated the epithelial and basement membrane thickness, mast cells (intact cells and degranulated cells subepithelially) and the presence or absence of blood vessels in oral lichen planus and oral lichenoid lesions. The evaluation was done using the periodic acid-schiff (PAS) and toluidine blue staining techniques on 20 cases each of oral lichen planus and oral lichenoid lesions and 5 control specimens of normal buccal mucosa. The results showed an increased number of degranulated mast cells in areas of basement membrane degeneration, increased vascularity and increased PAS-positive basement membrane thickness in oral lichen planus as compared with oral lichenoid lesions. Reduced epithelial thickness was found in oral lichen planus. The present study emphasizes the importance of these parameters in differentiating oral lichen planus from oral lichenoid lesions using special staining techniques.  (+info)

Lichen striatus in a child after immunization. A case report. (7/39)

Lichen striatus is a self-limited, lichenoid eruption particularly common in children. The lesions are located on extremities and less commonly on the trunk, and they follow the developmental lines of Blaschko. The etiology of lichen striatus is as yet unknown. It has been observed after infection or immunization in atopic patients and in siblings. The authors report on a 15-month-old girl that developed lichen striatus along the Blaschko lines on the trunk and one extremity after receiving the combined vaccine against measles, mumps, and rubella. Six months later, complete resolution of the skin lesions occurred without any treatment, leaving only slightly hypopigmented macules on the extremity.  (+info)

Bullous mycosis fungoides: a case report. (8/39)

Mycosis fungoides (MF) on extremely rare occasions is associated with vesiculobullous eruptions. We describe a 74-year-old man with previous documented histopathologic diagnosis of poikilodermic-type MF who recently developed flaccid acral bullae on erythematous MF plaques and on normal appearing skin. Histopathology and direct immunofluorescent studies revealed extensive lichenoid changes with intraepidermal bullae. Atypical lymphocyte infiltration was present at the dermoepidermal junction, in bulla fluid, and on the peripheral blood smear, but in lymph node and bone marrow tissue specimens atypical lymphocytes were absent. The plausible cause of these blister formations in cutaneous lymphoma bullosa may be from excessive epidermotropism or toxicity of the tumoral infiltrate.  (+info)

Lichenoid eruptions are skin reactions that resemble the appearance of lichen, a type of slow-growing fungus. These eruptions are characterized by flat, scaly bumps (papules) and rough, discolored patches (plaques) on the skin. They can be caused by various factors, including medications, medical conditions, or as a reaction to certain chemicals or substances that come into contact with the skin.

The term "lichenoid" refers to the resemblance of these eruptions to lichen, which is characterized by its distinctive appearance and growth pattern. Lichenoid eruptions can occur anywhere on the body but are most commonly found on sun-exposed areas such as the arms, legs, and trunk.

The exact cause of lichenoid eruptions can vary, but they are often associated with an autoimmune response in which the body's immune system mistakenly attacks healthy skin cells. This can lead to inflammation, redness, itching, and other symptoms associated with these eruptions. Treatment for lichenoid eruptions typically involves identifying and addressing the underlying cause, as well as managing symptoms with topical medications or other therapies.

Tooth eruption is the process by which a tooth emerges from the gums and becomes visible in the oral cavity. It is a normal part of dental development that occurs in a predictable sequence and timeframe. Primary or deciduous teeth, also known as baby teeth, begin to erupt around 6 months of age and continue to emerge until approximately 2-3 years of age. Permanent or adult teeth start to erupt around 6 years of age and can continue to emerge until the early twenties.

The process of tooth eruption involves several stages, including the formation of the tooth within the jawbone, the movement of the tooth through the bone and surrounding tissues, and the final emergence of the tooth into the mouth. Proper tooth eruption is essential for normal oral function, including chewing, speaking, and smiling. Any abnormalities in the tooth eruption process, such as delayed or premature eruption, can indicate underlying dental or medical conditions that require further evaluation and treatment.

I'm sorry for any confusion, but "Volcanic Eruptions" are not a medical term or concept. Volcanic eruptions refer to the release of molten rock, ash, and gases from a volcano's opening, or vent, onto the Earth's surface. This is a geological event that occurs due to the movement of tectonic plates and the build-up of pressure within the Earth's crust.

If you have any medical questions or terms you would like me to define, please feel free to ask!

A "drug eruption" is a general term used to describe an adverse skin reaction that occurs as a result of taking a medication. These reactions can vary in severity and appearance, and may include symptoms such as rash, hives, itching, redness, blistering, or peeling of the skin. In some cases, drug eruptions can also cause systemic symptoms such as fever, fatigue, or joint pain.

The exact mechanism by which drugs cause eruptions is not fully understood, but it is thought to involve an abnormal immune response to the medication. There are many different types of drug eruptions, including morphilliform rashes, urticaria (hives), fixed drug eruptions, and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), which is a severe and potentially life-threatening reaction.

If you suspect that you are experiencing a drug eruption, it is important to seek medical attention promptly. Your healthcare provider can help determine the cause of the reaction and recommend appropriate treatment. In some cases, it may be necessary to discontinue the medication causing the reaction and switch to an alternative therapy.

The term "lichenoid" derives from a resemblance to a lichen. Lichenoid+eruptions at the U.S. National Library of Medicine ... A lichenoid eruption is a skin disease characterized by damage and infiltration between the epidermis and dermis. Examples ... Bong JL, Lucke TW, Douglas WS (January 2000). "Lichenoid drug eruption with proton pump inhibitors". BMJ. 320 (7230): 283. doi: ... "Lichenoid drug eruption". Dermatology Online Journal. 15 (8): 13. ISSN 1087-2108. PMID 19891921. ...
Drug eruptions can mimic a wide range of dermatoses. The morphologies are myriad and include morbilliform (most common, see ... Lichenoid [19] - Amlodipine, antimalarials, beta-blockers, captopril, diflunisal, diltiazem, enalapril, furosemide, glimepiride ... Morbilliform eruption localized to striae has been described with clindamycin. [6] Morbilliform drug eruption. View Media ... encoded search term (Drug Eruptions) and Drug Eruptions What to Read Next on Medscape ...
Photo-distributed lichenoid eruption secondary to direct anti-viral therapy for hepatitis C.. Simpson CL, McCausland D, Chu EY ... Here, we report two cases of a photo-distributed lichenoid eruption that occurred within 1 month of starting anti-viral therapy ... This report provides the first histologic description of the cutaneous eruption associated with direct anti-viral therapy for ...
Categories: Lichenoid Eruptions Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, CopyrightRestricted ...
Cutaneous and mucosal lichenoid drug eruptions (e.g. lichen planus-like reactions) ... Treatment with Prolia may impair long-bone growth in children with open growth plates and may inhibit eruption of dentition. In ... and impaired tooth eruption. These changes were partially reversible in this model when dosing with the RANKL inhibitors was ... Neonatal RANK/RANKL knockout mice exhibited reduced bone growth and lack of tooth eruption. A corroborative study in 2-week-old ...
The same goes for ICI induced lichenoid eruptions, and ICI induced Stevens-Johnson Syndrome. These have very important ...
Acetylsalicylic acid may induce a lichenoid eruption. Dermatologica. 1988;177:19.. 51. Analysis of Reports to the Spontaneous ...
... lichenoid drug eruption, maculopapular rash, bullous dermatosis, eczematous drug eruption, erythema multiforme, pseudo-mycosis ... Clonazepam-induced lichenoid drug eruption: a case report. BMC Psychiatry. 2021;21(1):125. PubMed CrossRef Show Abstract ... fungoides, localized exfoliating eruptions, and alopecia.1-3. Generalized itching without apparent skin lesions caused by a ...
Mucocutaneous eruptions are often central to these untoward reactions, and an ever-expanding list of medications is linked to ... Oral lichenoid drug eruptions. Oral Dis. 1997 Jun. 3(2):58-63. [QxMD MEDLINE Link]. ... Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther. 2010 May-Jun. 23(3):251-67. [QxMD MEDLINE Link]. ... Fixed drug eruptions in the oral cavity often initially appear as areas of edema and erythema that lead to localized, ...
3. Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol. 1993;29(2 pt 1):249-255. ...
Eczematous and morbilliform eruptions are common, and graft-versus-host disease (GVHD) due to maternal engraftment has been ... A psoriasiform-lichenoid-spongiotic pattern with necrotic keratinocytes should trigger consideration of SCID and maternal ... We sought to better characterize SCID-related cutaneous disease observed prior to BMT and to compare the eruption to ... Cutaneous findings consisted of a scaling, erythematous maculopapular eruption spread widely over the trunk and extremities, ...
Rash/Drug Eruption includes: dermatitis (allergic, atopic, bullous, contact, exfoliative, infected), drug eruption, ... The more common presentations reported included papular or maculopapular rash, lichenoid, spongiotic or granulomatous ... Rash (drug eruption) is one of the most common adverse reactions associated with POTELIGEO. In Trial 1, 25% (80/319) of ... The onset of drug eruption is variable, and the affected areas and appearance vary. In Trial 1, the median time to onset was 15 ...
Drugs or contact allergens can cause lichenoid reactions as the main differential diagnosis of LP. LP is a T-cell mediated ... S. Halevy and A. Shai, "Lichenoid drug eruptions," Journal of the American Academy of Dermatology, vol. 29, no. 2, part 1, pp. ... D. Lage, P. B. Juliano, K. Metze, E. M. D. Souza, and M. L. Cintra, "Lichen Planus and lichenoid drug-induced eruption: a ... Epidermal changes are less common in lichenoid drug eruptions when compared to classic LP [94]. However, a higher concentration ...
... and summertime actinic lichenoid eruption. Limited to sun-exposed areas. ... Eruptions typically consist of a few lesions localized to one or a few sites. Distal aspects of the extremities, and less ... Caspary-Joseph spaces (Max-Joseph spaces)-Small clefts which form at the dermoepidermal junction secondary to the lichenoid ... Some eruptions were macular, whereas the majority had a slightly raised edge with central clearing. In all, 6 patients had ...
Parthenium dermatitis presenting as photosensitive lichenoid eruption. Hot dogs, for example, wont leak all over the place if ...
The features histologically resemble lichenoid eruptions (such as erythema multiforme, lichen planus, drug eruptions), and ... The clinical presentation is quite varied with some eruptions resembling erythema multiforme, pemphigoid and graft-versus-host ... In paraneoplastic pemphigus, there is usually an overt interface or lichenoid infiltrate associated with necrotic keratinocytes ...
... bullous drug eruptions (such as erythema multiforme and fixed drug eruption), lichenoid dermatitis, leukocytoclastic vasculitis ... This colorful description was used for a reaction pattern characterized by a bright-red, well-demarcated eruption, ... The differential diagnosis of SDRIFE includes fixed drug eruption, toxic erythema of chemotherapy, acute generalized ...
Rotstein E, Rotstein H. Drug eruptions with lichenoid histology produced by captopril. Australas J Dermatol. 1989;30:9-14. ... Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol. 2000;18:81-5. ... Worsening of the rash or a second wave of lesions is not uncommon before eventual spontaneous resolution of the eruption. ... A pityriasis rosea-like eruption secondary to bacillus Calmette-Guérin therapy for bladder cancer. Cutis. 1996;57:447-50. ...
Skin and Subcutaneous Tissue Disorders: drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption ...
Lichenoid drug eruption on the lower lip caused by anti-PD-1 monoclonal antibody: a case report and literature review. - ... November 2, 2021 , November 2, 2021 - Dominique comment on Lichenoid drug eruption on the lower lip caused by anti-PD-1 ... Right here we report the primary case, to our data, of oral lichenoid drug response triggered by toripalimab. A 78-year-old man ...
Drug-induced lichen planus (lichenoid drug eruption) *A dermatologic condition that is triggered by certain drugs (e.g., beta ... www.uptodate.com/contents/lichenoid-drug-eruption-drug-induced-lichen-planus. Last updated: December 9, 2016. Accessed: May 17 ... Lichenoid Drug Eruption (Drug-Induced Lichen Planus). . In: Post TW. , ed. UpToDate. Waltham, MA. : UpToDate. .. https:// ...
Skin and Appendages Disorders: acne, alopecia, burn, dermatitis, contact dermatitis, lichenoid dermatitis, eczema, furunculosis ... bullous eruption, cold clammy skin ...
Skin and Appendages Disorders: acne, alopecia, burn, dermatitis, contact dermatitis, lichenoid dermatitis, eczema, furunculosis ... bullous eruption, cold clammy skin ...
Keywords : stem cell transplantation; graft vs host disease; lichenoid eruptions; ulcer; xerostomia.. ... Results: The lichenoid lesions were reported in 82.5% of the studies, the most frequent changes among many others found, such ...
There was no family history of similar lesions and no history of any drug intake prior to the exacerbation of eruptions. ... Although Nekam′s disease (keratosis lichenoides chronica) may show a lichenoid histology underneath a parakeratotic epidermis ... a facial seborrheic dermatitis-like eruption with tiny confluent papules on the trunk and extremities in linear and reticulate ... arrays and an infundibulocentric and acrosyringocentric lichenoid interface dermatitis with numerous necrotic keratocytes ...
... intraoral fixed drug eruptions, lichenoid drug reactions, lupus erythematosus-like eruptions, pemphigus-like drug reactions, ... The so-called lichenoid, lupus-like, and pemphigus-like drug reactions resemble their namesakes clinically, as well as ...
Mucocutaneous eruptions are often central to these untoward reactions, and an ever-expanding list of medications is linked to ... Oral lichenoid drug eruptions. Oral Dis. 1997 Jun. 3(2):58-63. [QxMD MEDLINE Link]. ... Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther. 2010 May-Jun. 23(3):251-67. [QxMD MEDLINE Link]. ... Fixed drug eruptions in the oral cavity often initially appear as areas of edema and erythema that lead to localized, ...

No FAQ available that match "lichenoid eruptions"

No images available that match "lichenoid eruptions"